Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?
Oramed Pharmaceuticals Ownership Summary
Oramed Pharmaceuticals is owned by 17.21% institutional investors, 10.62% insiders, and 72.17% retail investors. Murchinson is the largest institutional shareholder, holding 4.20% of ORMP shares. iShares Micro-Cap ETF is the top mutual fund, with 0.21% of its assets in Oramed Pharmaceuticals shares.
ORMP Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Oramed Pharmaceuticals | 17.21% | 10.62% | 72.17% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Murchinson | 1.70M | 4.20% | $4.37M |
Bml capital management | 1.35M | 3.34% | $3.47M |
Boothbay fund management | 825.00K | 2.04% | $2.12M |
Rathbones group | 289.80K | 0.72% | $744.79K |
Two sigma advisers, lp | 259.10K | 0.64% | $665.89K |
Renaissance | 230.80K | 0.57% | $593.16K |
Bank of america corp /de/ | 173.24K | 0.43% | $445.23K |
Two sigma investments, lp | 150.37K | 0.37% | $386.44K |
Susquehanna group, llp | 125.83K | 0.31% | $323.38K |
Blackrock | 89.71K | 0.22% | $230.54K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bml capital management | 1.35M | 2.47% | $3.47M |
Murchinson | 1.70M | 0.67% | $4.37M |
Boothbay fund management | 825.00K | 0.05% | $2.12M |
Sage capital management | 16.75K | 0.02% | $43.05K |
Savvy advisors | 18.81K | 0.02% | $48.34K |
Marquette asset management | 33.31K | 0.01% | $80.61K |
Glass jacobson investment advisors | 10.54K | 0.01% | $27.09K |
Rathbones group | 289.80K | 0.00% | $744.79K |
Xtx topco | 15.47K | 0.00% | $39.77K |
N.e.w. advisory services | 12.36K | 0.00% | $29.91K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bml capital management | 1.35M | 2.47% | 504.54K |
Murchinson | 1.70M | 0.67% | 320.50K |
Boothbay fund management | 825.00K | 0.05% | 135.25K |
Renaissance | 230.80K | 0.00% | 108.70K |
Marquette asset management | 33.31K | 0.01% | 33.31K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Susquehanna group, llp | 125.83K | 0.00% | -218.61K |
Bank of america corp /de/ | 173.24K | - | -113.81K |
D. e. shaw | 38.57K | 0.00% | -31.94K |
Jane street group | 56.07K | - | -30.35K |
Assenagon asset management | - | - | -13.12K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Marquette asset management | 33.31K | 0.01% | 33.31K | $80.61K |
Millennium management | 19.46K | - | 19.46K | $50.00K |
Atria investments | 16.61K | 0.00% | 16.61K | $42.69K |
Golden state wealth management | 303.00 | 0.00% | 303.00 | $733.00 |
Russell investments group | 250.00 | - | 250.00 | $643.00 |
Sold Out
Holder | Change |
---|---|
Innealta capital | -13.00 |
Global retirement partners | -100.00 |
Mather group, llc. | -100.00 |
Qube research | -107.00 |
Tyler-stone wealth management | -300.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 56 | -3.45% | 6,959,416 | 17.28% | 17 | 7.99% | 22 | - | 14 | - |
Jun 30, 2024 | 58 | 9.43% | 5,933,790 | 12.77% | 14 | 8.67% | 22 | 4.76% | 14 | - |
Mar 31, 2024 | 53 | -10.17% | 5,261,693 | 2.01% | 13 | 8.00% | 21 | -19.23% | 14 | 27.27% |
Dec 31, 2023 | 59 | 1.72% | 5,157,843 | 124.71% | 12 | 39.17% | 26 | -3.70% | 11 | -15.38% |
Sep 30, 2023 | 58 | 9.43% | 2,295,285 | 0.82% | 5 | 17.65% | 27 | 17.39% | 13 | -18.75% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Micro-Cap ETF | 85.81K | 0.21% | - |
RBC Microcap Value I | 85.30K | 0.21% | 85.30K |
SPDR® Portfolio Developed Wld ex-US ETF | 48.40K | 0.12% | - |
MTF TR TA-Growth | 29.23K | 0.07% | -1.13K |
Dimensional US Core Equity 2 ETF | 26.31K | 0.07% | - |
I.B.I 70/30 | 26.00K | 0.06% | - |
Fidelity Nasdaq Composite Index | 25.45K | 0.06% | - |
DFA US Core Equity 2 I | 23.35K | 0.06% | - |
Avantis US Small Cap Equity ETF | 15.44K | 0.04% | - |
SPDR® S&P® International Small Cap ETF | 12.42K | 0.03% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 03, 2023 | Mayer Arie | - | Buy | $11.12K |
Apr 04, 2023 | Mayer Arie | - | Buy | $8.40K |
Mar 16, 2023 | KIDRON NADAV | President and CEO | Buy | $53.01K |
Mar 14, 2023 | KIDRON NADAV | President and CEO | Buy | $201.00K |
Mar 14, 2023 | Kidron Miriam | Chief Scientific Officer | Sell | $201.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q2 | 2 | - |
2023 Q1 | 4 | 3 |
ORMP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools